423 related articles for article (PubMed ID: 28651144)
1. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
[TBL] [Abstract][Full Text] [Related]
2. S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes.
Kinoshita R; Ishima Y; Ikeda M; Kragh-Hansen U; Fang J; Nakamura H; Chuang VT; Tanaka R; Maeda H; Kodama A; Watanabe H; Maeda H; Otagiri M; Maruyama T
J Control Release; 2015 Nov; 217():1-9. PubMed ID: 26302904
[TBL] [Abstract][Full Text] [Related]
3. S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects.
Ishima Y; Chen D; Fang J; Maeda H; Minomo A; Kragh-Hansen U; Kai T; Maruyama T; Otagiri M
Bioconjug Chem; 2012 Feb; 23(2):264-71. PubMed ID: 22225412
[TBL] [Abstract][Full Text] [Related]
4. Tuning of poly-S-nitrosated human serum albumin as superior antitumor nanomedicine.
Ishima Y; Fang J; Kragh-Hansen U; Yin H; Liao L; Katayama N; Watanabe H; Kai T; Suenaga A; Maeda H; Otagiri M; Maruyama T
J Pharm Sci; 2014 Jul; 103(7):2184-2188. PubMed ID: 24846171
[TBL] [Abstract][Full Text] [Related]
5. Reduction-Responsive and Multidrug Deliverable Albumin Nanoparticles: An Antitumor Drug to Abraxane against Human Pancreatic Tumor-Bearing Mice.
Hirakawa N; Ishima Y; Kinoshita R; Nakano R; Chuang VTG; Ando H; Shimizu T; Okuhira K; Maruyama T; Otagiri M; Ishida T
ACS Appl Bio Mater; 2021 May; 4(5):4302-4309. PubMed ID: 35006842
[TBL] [Abstract][Full Text] [Related]
6. Drug Delivery System for Refractory Cancer Therapy via an Endogenous Albumin Transport System.
Ishima Y; Maruyama T; Otagiri M; Ishida T
Chem Pharm Bull (Tokyo); 2020; 68(7):583-588. PubMed ID: 32611995
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induction of poly-S-nitrosated human serum albumin in resistant solid tumor under hypoxia can be restored by phosphodiesterase 5 inhibition.
Ikeda M; Ishima Y; Chuang VTG; Ikeda T; Kinoshita R; Watanabe H; Ishida T; Otagiri M; Maruyama T
Nitric Oxide; 2017 Sep; 69():28-34. PubMed ID: 28414103
[TBL] [Abstract][Full Text] [Related]
8. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
9. Damaging Tumor Vessels with an Ultrasound-Triggered NO Release Nanosystem to Enhance Drug Accumulation and T Cells Infiltration.
Xu Y; Liu J; Liu Z; Chen G; Li X; Ren H
Int J Nanomedicine; 2021; 16():2597-2613. PubMed ID: 33833514
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models.
Chen H; Huang S; Wang H; Chen X; Zhang H; Xu Y; Fan W; Pan Y; Wen Q; Lin Z; Wang X; Gu Y; Ding B; Chen J; Wu X
Drug Deliv; 2021 Dec; 28(1):1067-1079. PubMed ID: 34109887
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal models.
Ishima Y; Hara M; Kragh-Hansen U; Inoue A; Suenaga A; Kai T; Watanabe H; Otagiri M; Maruyama T
J Control Release; 2012 Nov; 164(1):1-7. PubMed ID: 23063551
[TBL] [Abstract][Full Text] [Related]
12. Poly-S-nitrosated human albumin enhances the antitumor and antimetastasis effect of bevacizumab, partly by inhibiting autophagy through the generation of nitric oxide.
Ishima Y; Inoue A; Fang J; Kinoshita R; Ikeda M; Watanabe H; Maeda H; Otagiri M; Maruyama T
Cancer Sci; 2015 Feb; 106(2):194-200. PubMed ID: 25457681
[TBL] [Abstract][Full Text] [Related]
13. Albumin-Based Nitric Oxide Traffic System for the Treatment of Intractable Cancers.
Ishima Y
Biol Pharm Bull; 2017; 40(2):128-134. PubMed ID: 28154250
[TBL] [Abstract][Full Text] [Related]
14. [Human Serum Albumin as Carrier in Drug Delivery Systems].
Ishima Y; Maruyama T
Yakugaku Zasshi; 2016; 136(1):39-47. PubMed ID: 26725666
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.
Takashima T; Kawajiri H; Nishimori T; Tei S; Nishimura S; Yamagata S; Tokunaga S; Mizuyama Y; Sunami T; Tezuka K; Ikeda K; Ogawa Y; Kashiwagi S; Noda S; Onoda N; Ishikawa T; Kudoh S; Takada M; Hirakawa K; Ohira M
Anticancer Res; 2018 Jan; 38(1):379-383. PubMed ID: 29277798
[TBL] [Abstract][Full Text] [Related]
16. Dual Therapeutic Effects of an Albumin-Based Nitric Oxide Donor on 2 Experimental Models of Chronic Kidney Disease.
Oshiro S; Ishima Y; Maeda H; Honda N; Bi J; Kinoshita R; Ikeda M; Iwao Y; Imafuku T; Nishida K; Miyamura S; Watanabe H; Otagiri M; Maruyama T
J Pharm Sci; 2018 Mar; 107(3):848-855. PubMed ID: 29074377
[TBL] [Abstract][Full Text] [Related]
17. Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature.
Araki T; Ogawara K; Suzuki H; Kawai R; Watanabe T; Ono T; Higaki K
J Control Release; 2015 Feb; 200():106-14. PubMed ID: 25553829
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
[TBL] [Abstract][Full Text] [Related]
19. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
[TBL] [Abstract][Full Text] [Related]
20. A switchable NO-releasing nanomedicine for enhanced cancer therapy and inhibition of metastasis.
Xu Y; Ren H; Liu J; Wang Y; Meng Z; He Z; Miao W; Chen G; Li X
Nanoscale; 2019 Mar; 11(12):5474-5488. PubMed ID: 30855625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
